Recent advances in mass-spectrometry based proteomics software, tools and databases

Q1 Pharmacology, Toxicology and Pharmaceutics Drug Discovery Today: Technologies Pub Date : 2021-12-01 DOI:10.1016/j.ddtec.2021.06.007
Ankit Halder, Ayushi Verma, Deeptarup Biswas, Sanjeeva Srivastava
{"title":"Recent advances in mass-spectrometry based proteomics software, tools and databases","authors":"Ankit Halder,&nbsp;Ayushi Verma,&nbsp;Deeptarup Biswas,&nbsp;Sanjeeva Srivastava","doi":"10.1016/j.ddtec.2021.06.007","DOIUrl":null,"url":null,"abstract":"<div><p>The field of proteomics<span> immensely depends on data generation and data analysis which are thoroughly supported by software and databases. There has been a massive advancement in mass spectrometry-based proteomics over the last 10 years which has compelled the scientific community to upgrade or develop algorithms, tools, and repository databases in the field of proteomics. Several standalone software, and comprehensive databases have aided the establishment of integrated omics<span> pipeline and meta-analysis workflow which has contributed to understand the disease pathobiology, biomarker discovery<span> and predicting new therapeutic modalities. For shotgun proteomics where Data Dependent Acquisition is performed, several user-friendly software are developed that can analyse the pre-processed data to provide mechanistic insights of the disease. Likewise, in Data Independent Acquisition, pipelines are emerged which can accomplish the task from building the spectral library to identify the therapeutic targets. Furthermore, in the age of big data analysis the implications of machine learning and cloud computing are appending robustness, rapidness and in-depth proteomics data analysis. The current review talks about the recent advancement, and development of software, tools, and database in the field of mass-spectrometry based proteomics.</span></span></span></p></div>","PeriodicalId":36012,"journal":{"name":"Drug Discovery Today: Technologies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"11","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today: Technologies","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1740674921000160","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 11

Abstract

The field of proteomics immensely depends on data generation and data analysis which are thoroughly supported by software and databases. There has been a massive advancement in mass spectrometry-based proteomics over the last 10 years which has compelled the scientific community to upgrade or develop algorithms, tools, and repository databases in the field of proteomics. Several standalone software, and comprehensive databases have aided the establishment of integrated omics pipeline and meta-analysis workflow which has contributed to understand the disease pathobiology, biomarker discovery and predicting new therapeutic modalities. For shotgun proteomics where Data Dependent Acquisition is performed, several user-friendly software are developed that can analyse the pre-processed data to provide mechanistic insights of the disease. Likewise, in Data Independent Acquisition, pipelines are emerged which can accomplish the task from building the spectral library to identify the therapeutic targets. Furthermore, in the age of big data analysis the implications of machine learning and cloud computing are appending robustness, rapidness and in-depth proteomics data analysis. The current review talks about the recent advancement, and development of software, tools, and database in the field of mass-spectrometry based proteomics.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于质谱的蛋白质组学软件、工具和数据库的最新进展
蛋白质组学领域极大地依赖于数据生成和数据分析,这些数据生成和分析完全由软件和数据库支持。在过去的10年里,基于质谱的蛋白质组学取得了巨大的进步,这迫使科学界升级或开发蛋白质组学领域的算法、工具和存储库数据库。一些独立的软件和全面的数据库已经帮助建立了集成的组学管道和荟萃分析工作流程,这有助于了解疾病的病理生物学,生物标志物的发现和预测新的治疗方式。对于执行数据依赖采集的散弹枪蛋白质组学,开发了几个用户友好的软件,可以分析预处理数据,以提供疾病的机制见解。同样,在数据独立采集中,出现了管道,可以完成从建立光谱库到识别治疗靶点的任务。此外,在大数据分析时代,机器学习和云计算的影响正在增加鲁棒性,快速和深入的蛋白质组学数据分析。本文综述了质谱技术在蛋白质组学领域的最新进展,以及软件、工具和数据库的发展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Discovery Today: Technologies
Drug Discovery Today: Technologies Pharmacology, Toxicology and Pharmaceutics-Drug Discovery
自引率
0.00%
发文量
0
期刊介绍: Discovery Today: Technologies compares different technological tools and techniques used from the discovery of new drug targets through to the launch of new medicines.
期刊最新文献
Proteomics advances towards developing SARS-CoV-2 therapeutics using in silico drug repurposing approaches Application of proteomic data in the translation of in vitro observations to associated clinical outcomes Advances in sample preparation for membrane proteome quantification Application of proteomics to understand maturation of drug metabolizing enzymes and transporters for the optimization of pediatric drug therapy Data-independent acquisition (DIA): An emerging proteomics technology for analysis of drug-metabolizing enzymes and transporters
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1